Basic symptoms and gray matter volumes of patients at clinical high risk for psychosis

scientific article published on 14 May 2020

Basic symptoms and gray matter volumes of patients at clinical high risk for psychosis is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1017/S0033291720001282
P698PubMed publication ID32404212

P50authorChantal MichelQ47268887
Frauke Schultze-LutterQ47527079
Jochen KindlerQ57005652
Michael KaessQ88067324
Benno G. SchimmelmannQ114401362
Martinus HaufQ114401363
Daniela HublQ114401364
P2860cites workRethinking schizophreniaQ22251086
Heterogeneity in Incidence Rates of Schizophrenia and Other Psychotic SyndromesQ22253032
Revisiting the Basic Symptom Concept: Toward Translating Risk Symptoms for Psychosis into Neurobiological TargetsQ26767499
Duration of untreated psychosis as predictor of long-term outcome in schizophrenia: systematic review and meta-analysisQ26824516
The precuneus: a review of its functional anatomy and behavioural correlatesQ29615024
Use of neuroanatomical pattern classification to identify subjects in at-risk mental states of psychosis and predict disease transitionQ30432820
Subjective symptoms of schizophrenia in research and the clinic: the basic symptom conceptQ30484431
Gray matter volumetric abnormalities associated with the onset of psychosisQ30580970
Neuroanatomy of vulnerability to psychosis: a voxel-based meta-analysis.Q33775024
The orbitofrontal cortex and rewardQ33871858
Diagnosing schizophrenia in the initial prodromal phaseQ33933362
Mapping adolescent brain change reveals dynamic wave of accelerated gray matter loss in very early-onset schizophreniaQ33944802
Accelerated brain aging in schizophrenia and beyond: a neuroanatomical marker of psychiatric disordersQ34048584
New generation antipsychotics versus low-potency conventional antipsychotics: a systematic review and meta-analysisQ34196968
Structure of the psychotic disorders classification in DSM-5.Q34346688
EPA guidance on the early detection of clinical high risk states of psychosesQ34465481
Regional gray matter volume abnormalities in the at risk mental stateQ34572449
EPA guidance on the early intervention in clinical high risk states of psychoses.Q34668473
Progressive reduction in cortical thickness as psychosis develops: a multisite longitudinal neuroimaging study of youth at elevated clinical riskQ34691699
Static and dynamic characteristics of cerebral blood flow during the resting state in schizophreniaQ34700962
Detecting the psychosis prodrome across high-risk populations using neuroanatomical biomarkersQ35096522
Progressive Structural Brain Changes During Development of PsychosisQ35898767
At risk or not at risk? A meta-analysis of the prognostic accuracy of psychometric interviews for psychosis predictionQ36118724
Psychosis-predictive value of self-reported schizotypy in a clinical high-risk sampleQ36119818
Insular volume abnormalities associated with different transition probabilities to psychosisQ36145094
Neuroanatomical maps of psychosis onset: voxel-wise meta-analysis of antipsychotic-naive VBM studiesQ36386404
Alterations of lateral temporal cortical gray matter and facial memory as vulnerability indicators for schizophrenia: An MRI study in youth at familial high-risk for schizophreniaQ36447719
The role of medial prefrontal cortex in memory and decision makingQ36582780
Brain Biomarkers of Vulnerability and Progression to PsychosisQ37124940
Temporal lobe volume abnormalities precede the prodrome: a study of children presenting antecedents of schizophreniaQ37228315
Structural Brain Abnormalities in Youth With Psychosis Spectrum SymptomsQ37307646
Middle and inferior temporal gyrus gray matter volume abnormalities in chronic schizophrenia: an MRI studyQ37475507
The size and burden of mental disorders and other disorders of the brain in Europe 2010.Q37928182
Basic symptoms and the prediction of first-episode psychosisQ37975261
Cognitive impairment in schizophreniaQ38048643
The psychosis high-risk state: a comprehensive state-of-the-art reviewQ38061036
Estimating the true global burden of mental illnessQ38724785
Ventricular enlargement and progressive reduction of cortical gray matter are linked in prodromal youth who develop psychosisQ38936884
Duration of unspecific prodromal and clinical high risk states, and early help-seeking in first-admission psychosis patientsQ38987087
A stratified model for psychosis prediction in clinical practiceQ39235804
Different duration of at-risk mental state associated with neurofunctional abnormalities. A multimodal imaging studyQ39289853
Abnormal involuntary movements are linked to psychosis-risk in children and adolescents: Results of a population-based studyQ40762877
Social cognition in schizophrenia: an overviewQ43192101
Interrelated neuropsychological and anatomical evidence of hippocampal pathology in the at-risk mental stateQ46349634
Prediction of psychosis in adolescents and young adults at high risk: results from the prospective European prediction of psychosis studyQ46816217
Morphometry of structural disconnectivity indicators in subjects at risk and in age-matched patients with schizophreniaQ47355545
Increased Striatal and Reduced Prefrontal Cerebral Blood Flow in Clinical High Risk for PsychosisQ47357393
Towards a neurodynamical understanding of the prodrome in schizophreniaQ47414443
Course of Cognitive Development From Infancy to Early Adulthood in the Psychosis SpectrumQ47550049
Prevalence and clinical relevance of interview-assessed psychosis-risk symptoms in the young adult community.Q47625645
Cognitive Subtypes of Schizophrenia Characterized by Differential Brain Volumetric Reductions and Cognitive DeclineQ47883296
Altered brain function directly related to structural abnormalities in people at ultra high risk of psychosis: longitudinal VBM-fMRI studyQ48152135
Orbitofrontal morphology in people at high risk of developing schizophreniaQ48168063
Neuroanatomical correlates of different vulnerability states for psychosis and their clinical outcomesQ48470818
Short-term functional outcome and premorbid adjustment in clinical high-risk patients. Results of the EPOS project.Q50672781
Evidence that better outcome of psychosis in women is reversed with increasing age of onset: a population-based 5-year follow-up study.Q51631434
Reliability and validity of the Mini International Neuropsychiatric Interview for Children and Adolescents (MINI-KID).Q51777179
Reductions in frontal, temporal and parietal volume associated with the onset of psychosis.Q51886500
Prediction Models of Functional Outcomes for Individuals in the Clinical High-Risk State for Psychosis or With Recent-Onset DepressionQ56876569
Psychopathology-a Precision Tool in Need of Re-sharpeningQ57073126
Inflammatory biomarkers in individuals at clinical high risk for psychosis (CHR-P): State or trait?Q57166177
Age effects on basic symptoms in the community: A route to gain new insight into the neurodevelopment of psychosis?Q58555392
Improving the clinical prediction of psychosis by combining ultra-high risk criteria and cognitive basic symptomsQ87419443
The interrelationship between schizotypy, clinical high risk for psychosis and related symptoms: Cognitive disturbances matterQ91227850
P921main subjectpsychosisQ170082
P304page(s)1-9
P577publication date2020-05-14
P1433published inPsychological MedicineQ7256364
P1476titleBasic symptoms and gray matter volumes of patients at clinical high risk for psychosis

Search more.